Table 2. Frequency of polymedication and treatment with fall-risk increasing drugs among cases (falls) and controls (no falls) in patients (n=31) receiving hemodialysis at the Nephrology Service of the Infanta Leonor University Hospital. Madrid, Spain, 2019.
| Oral Antidiabetics | Cases | Controls | |
|---|---|---|---|
| Yes | 2 (6.5%) | 5 (16.1%) | p*= 0.81 |
| No | 8 (25.8%) | 16 (51.6%) | |
| Antihypertensives | Case | Controls | |
| Yes | 8 (25.8%) | 6 (19.4%) | p * = 0.007 |
| No | 2 (6.5%) | 15 (48.4%) | |
| Benzodiazepines | Case | Controls | |
| Yes | 4 (12.9%) | 9 (29%) | p*= 0.88 |
| No | 6 (19.4%) | 12 (38.7%) | |
| Antidepressants | Case | Controls | |
| Yes | 1 (3.2%) | 3 (9.7%) | p*= 0.74 |
| No | 9 (29%) | 18 (58.1%) | |
| Sedatives | Case | Controls | |
| Yes | 2 (6.5%) | 4 (12.9%) | p*= 0.95 |
| No | 8 (25.8%) | 17 (54.8%) | |
| Antihistamines | Case | Controls | |
| Yes | 2 (6.5%) | 5 (16.1%) | p*= 0.81 |
| No | 8 (25.8%) | 16 (51.6%) | |
| ß2 Antagonists | Case | Controls | |
| Yes | 6 (19.4%) | 3 (9.7%) | p * = 0.009 |
| No | 4 (12.9%) | 18 (58.1%) | |
| Polymedication | Case | Controls | |
| Yes | 1 (3.2%) | 5 (16.1%) | p*= 0.363 |
| No | 9 (29%) | 16 (51.6%) |
*
p = Level of significance